Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts

Digestive Diseases and Sciences

Volumn 54, Issue 2, 2009, Pages 238-245

  Kawamura, Takato ^a,b   Andoh, Akira ^a   Nishida, Atsushi ^a   Shioya, Makoto ^a   Yagi, Yuhki ^a   Nishimura, Takashi ^a   Hashimoto, Takayoshi ^a   Tsujikawa, Tomoyuki ^a   Yasui, Hiroyuki ^b   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Histone acetylation; TNF ; Trichostatin A

Indexed keywords

ACETIC ACID; ALPHA SMOOTH MUSCLE ACTIN; BUTYRIC ACID; GELATINASE A; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROPIONIC ACID; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STROMELYSIN; TRICHOSTATIN A; VIMENTIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLON MUCOSA; COLON SECRETION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; COLON; ENZYME ACTIVATION; FATTY ACIDS, VOLATILE; FEMALE; FIBROBLASTS; HUMANS; HYDROXAMIC ACIDS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59449109616     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0348-1     Document Type: Article

References (31)

1. JH Cummings 1981 Short chain fatty acids in the human colon Gut 22 763 79 10.1136/gut.22.9.763
2. WE Roediger 1980 Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man Gut 21 793 8 10.1136/gut.21.9.793
3. JH Cummings GT Macfarlane 2002 Gastrointestinal effects of prebiotics Br J Nutr 87 Suppl 2 S145 51
4. CR Cavaglieri A Nishiyama LC Fernandes R Curi EA Miles PC Calder 2003 Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes Life Sci 73 1683 90 10.1016/S0024-3205(03) 00490-9
5. A Andoh T Tsujikawa Y Fujiyama 2003 Role of dietary fiber and short-chain fatty acids in the colon Curr Pharm Des 9 347 58 10.2174/1381612033391973
6. JA McBain A Eastman CS Nobel GC Mueller 1997 Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors Biochem Pharmacol 53 1357 68 10.1016/S0006-2952(96) 00904-5
7. W Scheppach 1996 Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group Dig Dis Sci 41 2254 9 10.1007/BF02071409
8. AH Steinhart A Brzezinski JP Baker 1994 Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas Am J Gastroenterol 89 179 83
9. P Vernia A Marcheggiano R Caprilli 1995 Short-chain fatty acid topical treatment in distal ulcerative colitis Aliment Pharmacol Ther 9 309 13
10. A Andoh Y Fujiyama K Hata 1999 Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells Clin Exp Immunol 118 23 9 10.1046/j.1365-2249.1999.01038.x
11. O Inatomi A Andoh K Kitamura H Yasui Z Zhang Y Fujiyama 2005 Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts J Gastroenterol 40 483 9 10.1007/s00535-005-1573-4
12. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J Biol Chem 274 21491 4 10.1074/jbc.274.31.21491
13. MP Vincenti 2001 The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression Methods Mol Biol 151 121 48
14. TT MacDonald M Bajaj-Elliott SL Pender 1999 T cells orchestrate intestinal mucosal shape and integrity Immunol Today 20 505 10 10.1016/S0167-5699(99) 01536-4
15. F Pallone G Monteleone 2001 Mechanisms of tissue damage in inflammatory bowel disease Curr Opin Gastroenterol 17 307 12 10.1097/00001574-200107000-00002
16. E Louis C Ribbens A Godon 2000 Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease Clin Exp Immunol 120 241 6 10.1046/j.1365-2249.2000.01227.x
17. B von Lampe B Barthel SE Coupland EO Riecken S Rosewicz 2000 Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease Gut 47 63 73 10.1136/gut.47.1.63
18. R Curi JA Bond PC Calder EA Newsholme 1993 Propionate regulates lymphocyte proliferation and metabolism Gen Pharmacol 24 591 7 10.1016/0306-3623(93) 90216-K
19. A Andoh S Bamba Y Fujiyama M Brittan NA Wright 2005 Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response J Gastroenterol 40 1089 99 10.1007/s00535-005-1727-4
20. A Andoh S Fujino T Okuno Y Fujiyama T Bamba 2002 Intestinal subepithelial myofibroblasts in inflammatory bowel diseases J Gastroenterol 37 Suppl 14 33 7
21. A Andoh A Ogawa S Bamba Y Fujiyama 2007 Interaction between interleukin-17-producing CD4 + T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation? J Gastroenterol 42 Suppl 17 29 33 10.1007/s00535-006-1926-7
22. T Okuno A Andoh S Bamba 2002 Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts Scand J Gastroenterol 37 317 24 10.1080/003655202317284228
23. S Bamba A Andoh H Yasui Y Araki T Bamba Y Fujiyama 2003 Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17 J Gastroenterol 38 548 54
24. DM Cortez MD Feldman S Mummidi 2007 IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta, NF-kappaB, and AP-1 activation Am J Physiol Heart Circ Physiol 293 H3356 65 10.1152/ajpheart.00928.2007
25. A Liacini J Sylvester WQ Li M Zafarullah 2002 Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes Matrix Biol 21 251 62 10.1016/S0945-053X(02) 00007-0
26. MJ Pazin JT Kadonaga 1997 What's up and down with histone deacetylation and transcription? Cell 89 325 8 10.1016/S0092-8674(00) 80211-1
27. KA Bode K Schroder DA Hume 2007 Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment Immunology 122 596 606 10.1111/j.1365-2567.2007.02678.x
28. PA McCue ML Gubler MI Sherman BN Cohen 1984 Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells J Cell Biol 98 602 8 10.1083/jcb.98.2.602
29. A Rada-Iglesias S Enroth A Ameur 2007 Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes Genome Res 17 708 19 10.1101/gr.5540007
30. SL Pender JJ Quinn IR Sanderson TT MacDonald 2000 Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells Am J Physiol Gastrointest Liver Physiol 279 G918 24
31. M Ailenberg M Silverman 2003 Differential effects of trichostatin A on gelatinase A expression in 3T3 fibroblasts and HT-1080 fibrosarcoma cells: implications for use of TSA in cancer therapy Biochem Biophys Res Commun 302 181 5 10.1016/S0006-291X(03) 00150-5